{"rows":[{"id":2436,"title":"Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.","authors":"Sherwood AM, Prisinzano TE","journal":"Expert review of clinical pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.1080/17512433.2018.1415755","pubmed_id":"29224406","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/29224406/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29224406","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29224406","source_url":"https://pubmed.ncbi.nlm.nih.gov/29224406/","doi":"10.1080/17512433.2018.1415755","pmid":"29224406","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2389,"title":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.","authors":"Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC","journal":"Expert review of clinical pharmacology","publication_date":"2018-09-01","publication_year":2018,"doi":"10.1080/17512433.2018.1511424","pubmed_id":"30102078","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/30102078/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Receptor Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30102078","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30102078/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30102078","source_url":"https://pubmed.ncbi.nlm.nih.gov/30102078/","doi":"10.1080/17512433.2018.1511424","pmid":"30102078","publication_date":"2018-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2269,"title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.","authors":"Greenway KT, Garel N, Jerome L, Feduccia AA","journal":"Expert review of clinical pharmacology","publication_date":"2020-06-01","publication_year":2020,"doi":"10.1080/17512433.2020.1772054","pubmed_id":"32478631","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32478631/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32478631","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32478631/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32478631","source_url":"https://pubmed.ncbi.nlm.nih.gov/32478631/","doi":"10.1080/17512433.2020.1772054","pmid":"32478631","publication_date":"2020-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2260,"title":"Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.","authors":"Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL","journal":"Expert review of clinical pharmacology","publication_date":"2020-08-01","publication_year":2020,"doi":"10.1080/17512433.2020.1794811","pubmed_id":"32648791","openalex_id":"https://openalex.org/W3040931347","source_url":"https://pubmed.ncbi.nlm.nih.gov/32648791/","substance_tags":"psilocybin","topic_tags":"Addiction,Aging,Review Article,Healthcare Workers,Toxicity","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32648791","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32648791/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32648791","source_url":"https://pubmed.ncbi.nlm.nih.gov/32648791/","doi":"10.1080/17512433.2020.1794811","pmid":"32648791","publication_date":"2020-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1915,"title":"Blinding and expectancy confounds in psychedelic randomized controlled trials.","authors":"Muthukumaraswamy SD, Forsyth A, Lumley T","journal":"Expert review of clinical pharmacology","publication_date":"2021-09-01","publication_year":2021,"doi":"10.1080/17512433.2021.1933434","pubmed_id":"34038314","openalex_id":"https://openalex.org/W3164618783","source_url":"https://pubmed.ncbi.nlm.nih.gov/34038314/","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34038314","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34038314/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34038314","source_url":"https://pubmed.ncbi.nlm.nih.gov/34038314/","doi":"10.1080/17512433.2021.1933434","pmid":"34038314","publication_date":"2021-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1281,"title":"Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.","authors":"Borkel LF, Rojas-Hernández J, Henríquez-Hernández LA, Santana Del Pino Á, Quintana-Hernández DJ","journal":"Expert review of clinical pharmacology","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1080/17512433.2023.2295997","pubmed_id":"38108102","openalex_id":"https://openalex.org/W4389900041","source_url":"https://pubmed.ncbi.nlm.nih.gov/38108102/","substance_tags":"psilocybin","topic_tags":"Addiction,Wellbeing,Personality Change,Clinical Trial,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:38108102","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38108102/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38108102","source_url":"https://pubmed.ncbi.nlm.nih.gov/38108102/","doi":"10.1080/17512433.2023.2295997","pmid":"38108102","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":705,"title":"From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.","authors":"Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK","journal":"Expert review of clinical pharmacology","publication_date":"2025-05-01","publication_year":2025,"doi":"10.1080/17512433.2025.2515866","pubmed_id":"40470809","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40470809/","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Spirituality,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:40470809","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40470809/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40470809","source_url":"https://pubmed.ncbi.nlm.nih.gov/40470809/","doi":"10.1080/17512433.2025.2515866","pmid":"40470809","publication_date":"2025-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":620,"title":"Psychedelic drugs for the treatment of substance use disorders.","authors":"Sofuoglu M, De Aquino JP, MacLean RR","journal":"Expert review of clinical pharmacology","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1080/17512433.2025.2541103","pubmed_id":"40726066","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40726066/","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40726066","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40726066","source_url":"https://pubmed.ncbi.nlm.nih.gov/40726066/","doi":"10.1080/17512433.2025.2541103","pmid":"40726066","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}}],"total":8,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Expert review of clinical pharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}